BME:CASH
BME:CASHCommercial Services

Prosegur Cash And 2 European Stocks That Could Be Trading Below Their Estimated Value

Amid renewed concerns over inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have seen a downturn, with major indices like the STOXX Europe 600 Index ending lower. In such an environment, identifying stocks that may be trading below their estimated value can offer potential opportunities for investors looking to navigate these challenging market conditions effectively.
BME:EDR
BME:EDRHospitality

eDreams ODIGEO (BME:EDR): Assessing Valuation After Guidance Cut and Shifting Growth Outlook

eDreams ODIGEO (BME:EDR) lowered its earnings guidance for 2026 and 2027, citing slower growth in its prime membership base and the effects of a shift toward flexible payment plans for subscribers. See our latest analysis for eDreams ODIGEO. eDreams ODIGEO’s share price has tumbled sharply, down 52% for the month and 59% year-to-date, reflecting fading momentum as investors digest the company’s lower earnings outlook and shifting growth profile. Despite a spike in recent net profit, the...
BME:GRF
BME:GRFBiotechs

Grifols (BME:GRF): Assessing Valuation After a Volatile Year in European Pharma

Grifols (BME:GRF) shares have moved recently, capturing attention after an extended stretch of volatility. Investors are weighing near-term developments as they consider a changing backdrop for the pharmaceutical sector in Europe. See our latest analysis for Grifols. After a turbulent year marked by sharp swings, Grifols’ 8.2% share price return since January stands out, especially as this rise has come despite recent negative momentum, including a 17.3% drop over the last three months and...
BME:SLR
BME:SLRRenewable Energy

Solaria Energía (BME:SLR) Surges After Net Income Jumps on Higher Revenue—Is Profitability the New Growth Engine?

Solaria Energía y Medio Ambiente has released its earnings results for the nine months ended September 30, 2025, reporting €258.91 million in revenue and €141.67 million in net income, both sharply higher compared to the previous year. Despite a slight decline in sales, the company achieved a very large year-on-year increase in net income, highlighting a marked improvement in profitability. We'll examine how Solaria's surge in net income, amid higher revenue, affects the company's investment...
BME:SAB
BME:SABBanks

Banco Sabadell (BME:SAB): Assessing Valuation After Q3 2025 Guidance Reaffirmation and Analyst Downgrade

Banco de Sabadell (BME:SAB) found itself in the spotlight after its Q3 2025 earnings reaffirmed full-year guidance and medium-term targets. However, investor focus quickly shifted following a prominent analyst downgrade citing geographic risks. See our latest analysis for Banco de Sabadell. Despite the recent analyst downgrade, Banco de Sabadell’s share price has soared over 71% year-to-date, reinforcing the market’s recognition of its turnaround and strong execution. Its one-year total...
BME:CLNX
BME:CLNXTelecom

Cellnex Telecom (BME:CLNX): Exploring Valuation After Rising Losses Despite Revenue Growth in Latest Results

Cellnex Telecom (BME:CLNX) just released its latest quarterly results, showing sales gains in both the third quarter and the nine-month period, but also a sharp rise in net losses compared to last year. See our latest analysis for Cellnex Telecom. The share price has been under pressure lately, with a 30-day return of -8.6% and a year-to-date decline of -16.4%, reflecting investor caution after Cellnex Telecom’s growing losses. Over the longer run, the 1-year total shareholder return stands...
BME:MAP
BME:MAPInsurance

A Fresh Look at Mapfre (BME:MAP) Valuation Following Strong Nine-Month 2025 Results

Mapfre (BME:MAP) just released financial results for the nine months ended September 2025, posting net income of €829 million, up from €653.5 million a year earlier. This has drawn attention from investors. See our latest analysis for Mapfre. Mapfre shares have shown impressive momentum, with a 63.4% year-to-date share price return as investors react positively to stronger earnings and a revived growth narrative. The longer-term picture is just as compelling, as evidenced by a five-year total...
BME:SAB
BME:SABBanks

The Bull Case For Banco Sabadell (BME:SAB) Could Change Following Analyst Downgrade After TSB Divestment

Banco Sabadell reported its Q3 2025 results, highlighting a recurrent return on tangible equity of 14.1%, confirmed guidance across all profit and loss lines, announced a second interim dividend payable in December, and outlined plans for an extraordinary dividend from the TSB divestment. An analyst downgrade followed, citing concerns about Sabadell’s growing reliance on the Spanish market after the TSB sale and questioning future revenue diversification. We'll examine how Sabadell's...
BME:GEST
BME:GESTAuto Components

Should Gestamp Automoción's (BME:GEST) Rising Q3 Profit Amid Revenue Decline Affect Investor Strategy?

Gestamp Automoción, S.A. has announced its third quarter 2025 results, reporting net income of €29.9 million, up from €20.9 million a year earlier, despite sales and revenue declines for both the quarter and the first nine months of the year. This outcome highlights the company's ability to improve profitability even as overall revenue and sales figures moved lower compared to the prior year period. We'll explore how Gestamp Automoción's higher quarterly net income amid ongoing revenue...